首页|期刊导航|实用医学杂志|瞄准未来:卵巢癌靶向治疗的新进展

瞄准未来:卵巢癌靶向治疗的新进展OA北大核心CSTPCD

Aiming for the future:The latest advances in targeted therapy for ovarian cancer

中文摘要英文摘要

卵巢癌是对全球女性健康构成重大威胁的疾病之一,在中国,卵巢癌在妇科恶性肿瘤中的复发率和病死率最高.传统治疗对晚期或复发性卵巢癌患者效果有限.最近的研究表明,靶向治疗在卵巢癌的治疗中取得了重要进展.本文将聚焦于国内外卵巢癌靶向治疗的相关研究,探讨其机制、应用、现状及面临的困境,旨在为卵巢癌治疗提供新的思路和方向.

Ovarian cancer represents a significant threat to women's health globally,with particularly high recurrence and mortality rates in China's context of gynecological malignancies.The effectiveness of traditional therapeutic approaches for advanced and recurrent ovarian cancer remains quite limited.However,recent studies have highlighted the substantial success of targeted therapies in managing ovarian cancer.This paper delves into both national and international research on ovarian cancer's targeted treatments,examining their mechanisms,applications,current landscape,and the challenges they face.It aims to offer innovative perspectives and directions for ovarian cancer treatment.

黄山高;吴月玲;张颖

广东医科大学附属医院妇产医学中心(广东湛江 524000)

临床医学

卵巢癌靶向治疗PARP抑制剂ADCs研究进展

ovarian cancertargeted rherapyPARP InhibitorsADCsresearch progress

《实用医学杂志》 2024 (014)

1901-1907 / 7

广东省自然科学基金项目(编号:2017A030313559)

10.3969/j.issn.1006-5725.2024.14.001

评论